Dyslipidemia Intervention in Metabolic Syndrome: Emphasis on Improving Lipids and Clinical Event Reduction

被引：20

作者：

Lavie, Carl J. ^{[1
]}

Milani, Richard V. ^{[1
]}

O'Keefe, James H. ^{[2
]}

机构：

[1] Univ Queensland, John Ochsner Heart & Vasc Inst, Ochsner Clin Sch, Dept Cardiovasc Dis,Sch Med, New Orleans, LA 70121 USA

[2] Univ Missouri, Mid Amer Heart Inst, Kansas City, MO 64110 USA

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2011年 / 341卷 / 05期

关键词：

Metabolic syndrome; HDL; Coronary heart disease; Triglycerides; Obesity; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; GLYCEMIC CONTROL; COLESEVELAM HYDROCHLORIDE; SECONDARY PREVENTION; RELEASE NIACIN; MORTALITY;

D O I：

10.1097/MAJ.0b013e31821483fa

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The metabolic syndrome is a common disorder characterized by central (especially intra-abdominal) obesity, hypertension, impaired glucose tolerance and atherogenic dyslipidemia (including the combination of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol). In this article, the authors review interventions to improve this lipid profile and potentially reduce the risk of major cardiovascular events in patients with metabolic syndrome.

引用

页码：388 / 393

页数：6

共 68 条

[1] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].

Alberti, K. G. M. M. ;

Eckel, Robert H. ;

Grundy, Scott M. ;

Zimmet, Paul Z. ;

Cleeman, James I. ;

Donato, Karen A. ;

Fruchart, Jean-Charles ;

James, W. Philip T. ;

Loria, Catherine M. ;

Smith, Sidney C., Jr. .

CIRCULATION, 2009, 120 (16) :1640-1645

[2]

Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO

[3]

2-S

[4] NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].

Alexander, CM ;

Landsman, PB ;

Teutsch, SM ;

Haffner, SM .

DIABETES, 2003, 52 (05) :1210-1214

[5]

[Anonymous], N ENGL J MED

[6]

[Anonymous], MAYO CLIN P

[7]

[Anonymous], CIRCULATION

[8] Beyond Low-Density Lipoprotein Cholesterol [J].

Arsenault, Benoit J. ;

Rana, Jamal S. ;

Stroes, Erik S. G. ;

Despres, Jean-Pierre ;

Shah, Prediman K. ;

Kastelein, John J. P. ;

Wareham, Nicholas J. ;

Boekholdt, S. Matthijs ;

Khaw, Kay-Tee .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 55 (01) :35-41

[9] Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia [J].

Bays, HE ;

Davidson, M ;

Jones, MR ;

Abby, SL .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (08) :1198-1205

[10] Rediscovering bile acid sequestrants [J].

Bell, D. S. H. ;

O'Keefe, James H. .

DIABETES OBESITY & METABOLISM, 2009, 11 (12) :1114-1121

← 1 2 3 4 5 6 7 →